Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
The Future of Clinical Trials in Idiopathic Pulmonary Fibrosis.
See All 12 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Future of Clinical Trials in Idiopathic Pulmonary Fibrosis.
Podolanczuk AJ, Richeldi L, Martinez FJ. The Future of Clinical Trials in Idiopathic Pulmonary Fibrosis. JAMA. 2023 05 09; 329(18):1554-1555.
View in:
PubMed
subject areas
Clinical Trials as Topic
Forecasting
Humans
Idiopathic Pulmonary Fibrosis
authors with profiles
Fernando J Martinez MD, MS